AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karr, S. C.
Right arrow Articles by Slavin, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karr, S. C.
Right arrow Articles by Slavin, J. L.
Agricola
Right arrow Articles by Karr, S. C.
Right arrow Articles by Slavin, J. L.

American Journal of Clinical Nutrition, Vol 66, 46-51, Copyright © 1997 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption

SC Karr, JW Lampe, AM Hutchins and JL Slavin
Department of Food Science and Nutrition, University of Minnesota, St Paul 55108-6099, USA.

Soybeans contain isoflavones, which have been associated with many health benefits, including decreased cancer risk. The purpose of our study was to measure urinary isoflavonoid excretion in response to daily consumption of soy that contained 0-36 mg isoflavones--a lower range than used in previous studies--and to compare urinary isoflavonoid excretion between equol excreters and nonexcreters. Fourteen men and women aged 20-40 y participated in the study. Half of the subjects were identified previously as equol excreters and the other half as equol nonexcreters. This randomized, double-blind, crossover study consisted of four 9-d diet treatment periods. During each treatment period participants consumed a low-photoestrogen controlled diet and a beverage containing 0, 5, 10, or 20 g soy protein. Urine collected on the last 3 d of each treatment period was analyzed for isoflavonoid (equol, O-desmethylangolensin, genistein, and daidzein) and lignan (enterodiol and enterolactone) contents by using isotope-dilution gas chromatography-mass spectrometry. There was a highly linear dose response of urinary isoflavonoid excretion to soy consumption, which did not differ significantly between equol excreters and nonexcreters. There were no significant differences in lignan excretion between the two diet treatments. Our results indicate that urinary isoflavonoid excretion is dose dependent in humans at low to moderate levels of soy consumption.


This article has been cited by other articles:


Home page
J. Am. Coll. Nutr.Home page
M. R. French, L. U. Thompson, and G. A. Hawker
Validation of a Phytoestrogen Food Frequency Questionnaire with Urinary Concentrations of Isoflavones and Lignan Metabolites in Premenopausal Women
J. Am. Coll. Nutr., February 1, 2007; 26(1): 76 - 82.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
B. J. Trock, L. Hilakivi-Clarke, and R. Clarke
Meta-analysis of soy intake and breast cancer risk.
J Natl Cancer Inst, April 5, 2006; 98(7): 459 - 471.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. M. Sacks, A. Lichtenstein, L. Van Horn, W. Harris, P. Kris-Etherton, M. Winston, and for the American Heart Association Nutrition Commi
Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals From the Nutrition Committee
Circulation, February 21, 2006; 113(7): 1034 - 1044.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
Y. Ma, D. Chiriboga, B. C. Olendzki, R. Nicolosi, P. A. Merriam, and I. S. Ockene
Effect of Soy Protein Containing Isoflavones on Blood Lipids in Moderately Hypercholesterolemic Adults: A Randomized Controlled Trial
J. Am. Coll. Nutr., August 1, 2005; 24(4): 275 - 285.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. Atkinson, C. L. Frankenfeld, and J. W. Lampe
Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health
Experimental Biology and Medicine, March 1, 2005; 230(3): 155 - 170.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. L. Frankenfeld, C. Atkinson, W. K. Thomas, E. L. Goode, A. Gonzalez, T. Jokela, K. Wahala, S. M. Schwartz, S. S. Li, and J. W. Lampe
Familial Correlations, Segregation Analysis, and Nongenetic Correlates of Soy Isoflavone-Metabolizing Phenotypes
Experimental Biology and Medicine, October 1, 2004; 229(9): 902 - 913.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez
Polyphenols: food sources and bioavailability
Am. J. Clinical Nutrition, May 1, 2004; 79(5): 727 - 747.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. B. Grace, J. I. Taylor, Y.-L. Low, R. N. Luben, A. A. Mulligan, N. P. Botting, M. Dowsett, A. A. Welch, K.-T. Khaw, N. J. Wareham, et al.
Phytoestrogen Concentrations in Serum and Spot Urine as Biomarkers for Dietary Phytoestrogen Intake and Their Relation to Breast Cancer Risk in European Prospective Investigation of Cancer and Nutrition-Norfolk
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 698 - 708.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. D. R. Setchell, N. M. Brown, P. B. Desai, L. Zimmer-Nechimias, B. Wolfe, A. S. Jakate, V. Creutzinger, and J. E. Heubi
Bioavailability, Disposition, and Dose-Response Effects of Soy Isoflavones When Consumed by Healthy Women at Physiologically Typical Dietary Intakes
J. Nutr., April 1, 2003; 133(4): 1027 - 1035.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. W. Lampe
Isoflavonoid and Lignan Phytoestrogens as Dietary Biomarkers
J. Nutr., March 1, 2003; 133(3): 956S - 964.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. D. Setchell, M. S Faughnan, T. Avades, L. Zimmer-Nechemias, N. M Brown, B. E Wolfe, W. T Brashear, P. Desai, M. F Oldfield, N. P Botting, et al.
Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women
Am. J. Clinical Nutrition, February 1, 2003; 77(2): 411 - 419.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. D. R. Setchell, N. M. Brown, and E. Lydeking-Olsen
The Clinical Importance of the Metabolite Equol--A Clue to the Effectiveness of Soy and Its Isoflavones
J. Nutr., December 1, 2002; 132(12): 3577 - 3584.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. R Shelnutt, C. O Cimino, P. A Wiggins, M. J. Ronis, and T. M Badger
Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage
Am. J. Clinical Nutrition, September 1, 2002; 76(3): 588 - 594.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. Tsunoda, S. Pomeroy, and P. Nestel
Absorption in Humans of Isoflavones from Soy and Red Clover Is Similar
J. Nutr., August 1, 2002; 132(8): 2199 - 2201.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Nicholls, B. L. Lasley, S. T. Nakajima, K. D. R. Setchell, and B. O. Schneeman
Effects of Soy Consumption on Gonadotropin Secretion and Acute Pituitary Responses to Gonadotropin-Releasing Hormone in Women
J. Nutr., April 1, 2002; 132(4): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Atkinson, H. E. Skor, E. D. Fitzgibbons, D. Scholes, C. Chen, K. Wahala, S. M. Schwartz, and J. W. Lampe
Overnight Urinary Isoflavone Excretion in a Population of Women Living in the United States, and Its Relationship to Isoflavone Intake
Cancer Epidemiol. Biomarkers Prev., March 1, 2002; 11(3): 253 - 260.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. Maskarinec, A. E. Williams, J. S. Inouye, F. Z. Stanczyk, and A. A. Franke
A Randomized Isoflavone Intervention among Premenopausal Women
Cancer Epidemiol. Biomarkers Prev., February 1, 2002; 11(2): 195 - 201.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. J. J. de Kleijn, Y. T. van der Schouw, P. W. F. Wilson, H. Adlercreutz, W. Mazur, D. E. Grobbee, and P. F. Jacques
Intake of Dietary Phytoestrogens Is Low in Postmenopausal Women in the United States: The Framingham Study1-4
J. Nutr., June 1, 2001; 131(6): 1826 - 1832.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. d. Tonkelaar, L. Keinan-Boker, P. Van’t Veer, C. J. M. Arts, H. Adlercreutz, J. H. H. Thijssen, and P. H. M. Peeters
Urinary Phytoestrogens and Postmenopausal Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 223 - 228.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
J. W. Lampe, H. E. Skor, S. Li, K. Wähälä, W. N. Howald, and C. Chen
Wheat Bran and Soy Protein Feeding Do Not Alter Urinary Excretion of the Isoflavan Equol in Premenopausal Women
J. Nutr., March 1, 2001; 131(3): 740 - 744.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Stumpf, P. Pietinen, P. Puska, and H. Adlercreutz
Changes in Serum Enterolactone, Genistein, and Daidzein in a Dietary Intervention Study in Finland
Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1369 - 1372.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
X. Xu, A. M. Duncan, K. E. Wangen, and M. S. Kurzer
Soy Consumption Alters Endogenous Estrogen Metabolism in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 781 - 786.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
A. Scalbert and G. Williamson
Dietary Intake and Bioavailability of Polyphenols
J. Nutr., August 1, 2000; 130(8): 2073S - 2085.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. M. Duncan, B. E. Merz-Demlow, X. Xu, W. R. Phipps, and M. S. Kurzer
Premenopausal Equol Excretors Show Plasma Hormone Profiles Associated with Lowered Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 581 - 586.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
L. Wroblewski Lissin and J. P. Cooke
Phytoestrogens and cardiovascular health
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1403 - 1410.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. R. Shelnutt, C. O. Cimino, P. A. Wiggins, and T. M. Badger
Urinary Pharmacokinetics of the Glucuronide and Sulfate Conjugates of Genistein and Daidzein
Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 413 - 419.
[Abstract] [Full Text]


Home page
J. Am. Coll. Nutr.Home page
L. R. White, H. Petrovitch, G. W. Ross, K. Masaki, J. Hardman, J. Nelson, D. Davis, and W. Markesbery
Brain Aging and Midlife Tofu Consumption
J. Am. Coll. Nutr., April 1, 2000; 19(2): 242 - 255.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S.-J. Su, T.-M. Yeh, H.-Y. Lei, and N.-H. Chow
The Potential of Soybean Foods as a Chemoprevention Approach for Human Urinary Tract Cancer
Clin. Cancer Res., January 1, 2000; 6(1): 230 - 236.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. W. Lampe, D. R. Gustafson, A. M. Hutchins, M. C. Martini, S. Li, K. Wähälä, G. A. Grandits, J. D. Potter, and J. L. Slavin
Urinary Isoflavonoid and Lignan Excretion on a Western Diet: Relation to Soy, Vegetable, and Fruit Intake
Cancer Epidemiol. Biomarkers Prev., August 1, 1999; 8(8): 699 - 707.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
Y. Zhang, G.-J. Wang, T. T. Song, P. A. Murphy, and S. Hendrich
Urinary Disposition of the Soybean Isoflavones Daidzein, Genistein and Glycitein Differs among Humans with Moderate Fecal Isoflavone Degradation Activity
J. Nutr., May 1, 1999; 129(5): 957 - 962.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
P. FANTI, B. P. SAWAYA, L. J. CUSTER, and A. A. FRANKE
Serum Levels and Metabolic Clearance of the Isoflavones Genistein and Daidzein in Hemodialysis Patients
J. Am. Soc. Nephrol., April 1, 1999; 10(4): 864 - 871.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
P. D Nesbitt, Y. Lam, and L. U Thompson
Human metabolism of mammalian lignan precursors in raw and processed flaxseed
Am. J. Clinical Nutrition, March 1, 1999; 69(3): 549 - 555.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. H. Lichtenstein
Soy Protein, Isoflavones and Cardiovascular Disease Risk
J. Nutr., October 1, 1998; 128(10): 1589 - 1592.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
S. Watanabe, M. Yamaguchi, T. Sobue, T. Takahashi,, T. Miura, Y. Arai, W. Mazur, K. Wähälä, and H. Adlercreutz
Pharmacokinetics of Soybean Isoflavones in Plasma, Urine and Feces of Men after Ingestion of 60 g Baked Soybean Powder (Kinako)
J. Nutr., October 1, 1998; 128(10): 1710 - 1715.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by The American Society for Nutrition